Keywords
Genotype
subtype
How to Cite
Abstract
Hepatitis C is an infectious disease with variable clinical evolution, generally slow and progressive, caused by a RNA virus termed HCV (hepatitis C virus). This virus presents a structure composed by an external envelop, protein core, and a single strand RNA with approximately 9,5 Kb. RNA virus usually present a high mutation level resulting in diverse genomic sequences , and owing to these various genotypes and subtypes are evolved. HCV genotypes 1, 2 and 3 have been worldwide disseminated, being types 4 and 5 specially in Africa, and type 6 has been found in Asia. In Brazil the mostly frequent genotypes are 1, 2, and 3. The present study evaluated 1.018 plasma samples anti-HCV positive on ELISA assay, and HCV RNA positive by means of RT-PCR (Roche®). These plasma samples were sent from following cities of São Paulo state: Botucatu (N=508), Bauru (N= 415), and Assis (N= 95). Genotyping was performed by means of LiPA (Line probe assay - Bayer) which allows to analyze six HCV genotypes, and the most common subtypes. HCV genotypes regional distribution was 62.9% of genotype 1 ,and 34.5% of genotype 3 . Genotype 2 was found in Botucatu and Bauru regions only in a frequency of 2.1%, and genotype 5 was shown in Botucatu (0.2%) only . HCV subtypes distribution was as follow: in Botucatu region – subtype 1a (25%), 1b (29.3%), 1a/1b (3.5%), 2b (0.6%), 3a (35.0%), 5a (0.2%); in Bauru region – subtypes 1a (31.1%), 1b (27.2%), 1a /1b (2.4%), 2 b (1.9%), 2 a/2c (0.2%), 3a (32.3%); in Assis region – subtypes 1a (26.3%), 1b (26.3%), 1a /1b (2.1%), 3a (41.1%). The used genotyping technique did not allow to perform the subtypes characterization in 4.1% of samples. The HCV genotypes distribution in these São Paulo state regions was similar to those observed in other Brazilian and world sites, although some regional differences on HCV subtypes were observed , such as the occurrence of African genotypes (5 and 5a) in Botucatu region.
References
1. Nadler J. AIDS : etiologia. In: Veronesi R, Foccacia SR, editores. Tratado de Infectologia. São Paulo: Atheneu; 1996 p.83-6.
2. Brasil. Ministério da Saúde. Secretaria de Assistência à Saúde. Portaria n°863, de 4 de novembro de 2002, Protocolos clínicos e diretrizes terapêuticas: Hepatite Viral Crônica C [acesso 2003 apr 08] Disponível em: URL:http://www.grupoesperanca.org.br.
3. Grupo de Estudos da Sociedade de Hepatologia. Epidemiologia da infecção pelo Vírus da Hepatite C no Brasil, 2005a [cited 2005 ago]. Available from: URL: www.sbhepatologia.org.br.
4. National Center for Brotechnology Information - Taxonomy browser;taxonomy ID:11103. Hepatitis C virus [cited 2003 april 08] Available from: URL: http://www.ncbi.nlm.gov/Taxonomy/Browser.
5. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghtown M.Isolation of a cDNAclone derived from a blood born non-A, non-B hepatitisgenome. Science 1989; 244:359-62.
6. Conte VP. Hepatite crônica por Virus C. Arq Gastroenterol 2000; 37:187-94.
7. Silva MD. Hepatite C e testes diagnósticos. Cad. de Farm 2001; 17:111-5.
8. Barteuschlager R, Lohmann V. Replication of hepatitis C virus. J Gen Virol2000; 81:1631-48.
9. Penin F, Dubuisson J, Rey FA, Moradpour D, Pawlotsky JM. StructuralBiology of Hepatitis C virus. Hepatology 2004;39(1):05-19.
10. Brasil. Secretaria de Estado da Saúde. Centro de Vigilância Epidemiológica“Prof. Alexandre Vranjac”. Guia de orientações técnicas Hepatites B e C. SãoPaulo; 2002.
11.Bravo R, Soriano V, Garcia Samaniego J, Gonzalez J, Castro A, ColmeneroM, et al. Prevalence of the genotypes of the hepatitis C virus in Spanis drugaddicts with chronic hepatitis C. Spanish Group for the Study of Viral Hepatitisin HIV Positive Patients. Rev Clin Esp 1996; 196:673-7.
12. Busek S, Oliveira G. Molecular epidemiology of the hepatitis C virus in Brazil.Genet Mol Res 2003; 2:117-23.
13. Janis and friends hepatitis C support web site. Genotypes. Information ontreatment according to genotype [serial on line] 2005b [cited 2005 sept 16].Avaiable from: URL: http://janis7hepc.com/genotypes.htm.
14. Peter S, Bukh J, Combet C, Deléage G, Enotomo N, Feinstone S, et al.Consensus proposal for a unified system of nomenclature of hepatitis C virusgenotypes. Hepatology 2005;42: 962-73.
15. Grupo vontade de viver de apoio aos portadores do virus da hepatite C.Tratamento usual [serial on line] 2005b [cited 2005 sept 16]. Available from:URL: www.vontadedeviver.org.br.
16. Jardim ACG, Fachinni RM, Sanchez FE, Carvalho Salles AB, Souza FP,Zanetto DM, et al. Identification and genotyping of the Hapatitis C virus inindividuals from a blood center. J Braz Soc Virol 2004; 9:155 -6.
17. Bassit L, Ribeiro dos Santos G, Silva LC, Takei K, Villaca P, DavidNeto E, et al. Genotype distributions of hepatitis C virus in São Paulo,Brazil: rare subtype found. Hepatology 1999; 29:994-95.
18. Spina AMM, Souza AT, Fernandes RB, Gushiken EKK, Ferraz M,. CorvinoSM, et al. Hepatitis C virus genotypes in the state of Sao Paulo, Brazil.In: Abstract of the 12th International Symposium on Hepatitis C Virus andRelated Viruses Montreal, 2005: P-08.
19. Oliveira MLA, Bastos FI, Sabino RR, Paetzold U, Schreier E, Pauli G,et al. Distribution of HCV genotypes among different exposure categories in Brazil.Braz J Med Biol Res 1999; 2:79-282.
20. Paraná R, Vitvitski L, Berby F, Portugal M, Cotrim HP, Cavalcanti A. et al.HCV infection in northeastern Brazil: unexpected high prevalence of genotype 3a and absence of African genotypes. Arq Gastroenterol 2000; 37:213-6.
21. Wanderlei Silva DM, Gonzaga RS, Rodart IF, Lopes GB, Braga JHM,Ramalho Neto CE. and Reis MG. Distribution of Hepatitis C virus genotypesin Alagoas state, Brazil. J Braz Soc Virol 2004; 9:154-5.
22. Oliveira RV, Fialho MV, Espírito-Santo MP, Silva LDA, Yoshida CFT, LampeE. Comparison of hepatitis C virus genotypes tested by line probe assay (LiPA)and nucleotide sequencing analyses. J Braz Soc Virol 2004; 9:156.
23. Lampe E, Espírito-Santo MP, Oliveira JM, Oliveira RV, Fialho MV,DeAlmeida AJ, et al. Genomic variability of hepatitis C virus strains fromstates of Bahia, Goiás and Rio de Janeiro, Brazil. J Braz Soc Virol 2004;9:156.
24. Guia de orientação técnica: HCV Genotype Assay (LiPA) Versant TM Bayer©, GO4622 Rev.0, 2002;13.
25. Kato N, Sekiya H, Ootsuyama Y, Nakazawa t, Hijikata M, Ohkoshi S,et al. Humoral immune response to hipervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol 1993; 67:3923-30.
26. Taniguchi S, Okamoto M, Sakamoto M, Kojima M, Tsuda F, Tanaka T,et al. A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for a escape fromantibody. Virology 1993; 195:297-301.
27. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 1995; 15:41-63.
28. Sakai A, Shuichi K, Honda M, Matsushita E, Kobayashi K. Quasispecies of hepatitis C virus in serum and in three different parts of the liver of patientswith chronic hepatitis. Hepatology 1999; 30:556-61.
29. Simmonds P, Mellor J, Sanchez Tapias JM, Alberti A, Priet J, ColomboM, et al. Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients. J Hepatol 1996; 24:517-24.
30. Brechot C. The direct interplay between HCV NS5A protein and interferon transduction signal: from clinical to basic science. J Hepatol 1999; 30:1152-54.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2006 Instituto Adolfo Lutz Journal